Vir Biotechnology, Inc.
VIR · NASDAQ · USD
$11.69
+0.57 5.13%todayNot financial advice.
- Open
- 11.11
- Day range
- 10.97 - 12.00
- 52-week range
- 4.82 - 12.00
- Volume
- 1.47M
- Market cap
- 1.98B
- P/E ratio
- —
- EPS
- -1.86
- Dividend yield
- 0.00%
- Beta
- 1.12
Performance
W
+1.21%
1M
+5.89%
3M
+13.28%
6M
+18.44%
YTD
+93.86%
Y
+92.59%
5Y
−65.90%
All
−27.62%
In the news
Oct 8
Vir Biotechnology Receives FDA Fast Track Designation for Prostate Cancer Drug VIR-5500
Vir Biotechnology received FDA Fast Track designation for its prostate cancer treatment VIR-5500, with Phase 3 trials planned for 2027.
Company news
Oct 8
Vir Biotechnology Receives FDA Fast Track Designation for Cancer Drug VIR-5500
Vir Biotechnology received FDA Fast Track designation for its drug VIR-5500, which could speed up the development and review process.
Company news
Oct 8
Vir Biotechnology Receives FDA Fast Track Status for Prostate Cancer Drug
Vir Biotechnology was granted FDA Fast Track status for its prostate cancer drug VIR-5500, which is being co-developed with Astellas Pharma.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-VIR" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Vir Biotechnology, Inc. (VIR) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-VIR">VIR stock price</a> by FreeTheAI Stocks</p>